Sangart Garners $50,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    6175 Lusk Blvd San Diego, CA 92121
  • Company Description
    Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    This series G funding will allow us to continue advancing the development of our medicines and get them as quickly as possible to patients in need. We continue to see promise in our MP4-based medicines in the treatment of patients who experience an acute traumatic injury and in patients with sickle cell disease suffering from a vaso-occlusive crisis.
  • M&A Terms
  • Venture Investor
    Leucadia National Corp
  • Venture Investor

Trending on Xconomy